Thoroughbred Financial Services, LLC Moderna, Inc. Transaction History

Thoroughbred Financial Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $252,112 - $331,085	2,615 New	2,615 $270,000
Q3 2019 Nov 12, 2019	SELL	$12.26 - $18.07 $142,216 - $209,612	-11,600 Closed	0 $0
Q2 2019 Jul 16, 2019	SELL	$13.7 - $28.34 $2.17 Million - $4.48 Million	-158,224 Reduced 93.17%	11,600 $0
Q2 2019 Jul 16, 2019	BUY	$13.7 - $28.34 $2.17 Million - $4.5 Million	158,724 Added 1429.95%	169,824 $0
Q4 2018 Feb 13, 2019	BUY	$13.52 - $18.8 $150,072 - $208,680	11,100 New	11,100 $169,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.